Mays D C, Hilliard J B, Wong D D, Chambers M A, Park S S, Gelboin H V, Gerber N
Department of Pharmacology, College of Medicine, Ohio State University, Columbus.
J Pharmacol Exp Ther. 1990 Aug;254(2):720-31.
The in vitro bioactivation of 8-MOP was studied in liver microsomes of male CD-1 mice. In 10-min incubations with 40 microM [14C]8-MOP, covalent binding (mean +/- S.D.) was 1.8 +/- 0.4, 3.1 +/- 0.6 and 5.4 +/- 0.4 nmol/mg protein, respectively, in microsomes from mice pretreated for 3 days with vehicle, phenobarbital or beta-naphthoflavone (BNF). A monoclonal antibody (MAb 1-7-1), which recognizes isozymes of cytochrome P-450 induced by 3-methylcholanthrene (P1-450 and P3-450), selectively inhibited the metabolism of 8-MOP (-57%) and covalent binding of its metabolites (-40%) in microsomes from mice pretreated with BNF, but had no effect in microsomes of mice pretreated with phenobarbital or vehicle. Monoclonal antibody 2-66-3, which recognizes the major isozymes of rat cytochrome P-450 induced by phenobarbital and unknown isozymes in the mouse, enhanced the covalent binding of 8-MOP metabolites in microsomes of mice pretreated with vehicle (+74%), phenobarbital (+44%) or BNF (+31%) without affecting the disappearance of 8-MOP. Preincubation of liver microsomes from BNF-pretreated mice with 40 microM 8-MOP decreased the activity of 7-ethoxycoumarin de-ethylase in a time-dependent manner. Preincubation with 40 microM 8-MOP for 10 min decreased the Vmax from 3.4 to 1.2 nmol/min/mg protein and increased the Michaelis constant from 46 to 90 microM, thus demonstrating mixed competitive and noncompetitive inhibition of 7-ethoxycoumarin de-ethylase. Cysteine trapped three-fourths of the reactive intermediates of 8-MOP but was ineffective in preventing the irreversible inhibition of 7-ethoxycoumarin de-ethylase activity or the 45% spectral loss of cytochrome P-450. Cysteine was ineffective probably because it did not prevent the irreversible binding of metabolites of 8-MOP to cytochrome P-450. There was no spectral evidence that 8-MOP formed cytochrome P-420 or metabolite-intermediate complexes with cytochrome P-450. These findings support the hypothesis that irreversible inactivation of cytochrome P-450 by 8-MOP is caused by modification of the apoprotein by reactive metabolites.
在雄性CD-1小鼠的肝脏微粒体中研究了8-甲氧基补骨脂素(8-MOP)的体外生物活化作用。在用40微摩尔[14C]8-MOP进行10分钟孵育时,分别用赋形剂、苯巴比妥或β-萘黄酮(BNF)预处理3天的小鼠微粒体中的共价结合(平均值±标准差)分别为1.8±0.4、3.1±0.6和5.4±0.4纳摩尔/毫克蛋白质。一种单克隆抗体(MAb 1-7-1)可识别由3-甲基胆蒽诱导的细胞色素P-450同工酶(P1-450和P3-450),它选择性地抑制了用BNF预处理的小鼠微粒体中8-MOP的代谢(-57%)及其代谢产物的共价结合(-40%),但对用苯巴比妥或赋形剂预处理的小鼠微粒体没有影响。单克隆抗体2-66-3可识别由苯巴比妥诱导的大鼠细胞色素P-450主要同工酶以及小鼠中未知的同工酶,它增强了用赋形剂(+74%)、苯巴比妥(+44%)或BNF(+31%)预处理的小鼠微粒体中8-MOP代谢产物的共价结合,而不影响8-MOP的消失。用40微摩尔8-MOP对用BNF预处理的小鼠肝脏微粒体进行预孵育,可使7-乙氧基香豆素脱乙基酶的活性呈时间依赖性降低。用40微摩尔8-MOP预孵育10分钟可使Vmax从3.4降至1.2纳摩尔/分钟/毫克蛋白质,并使米氏常数从46增至90微摩尔,从而证明对7-乙氧基香豆素脱乙基酶有混合竞争性和非竞争性抑制作用。半胱氨酸捕获了8-MOP四分之三的反应性中间体,但在防止7-乙氧基香豆素脱乙基酶活性的不可逆抑制或细胞色素P-450 45%的光谱损失方面无效。半胱氨酸无效可能是因为它没有阻止8-MOP代谢产物与细胞色素P-450的不可逆结合。没有光谱证据表明8-MOP与细胞色素P-450形成细胞色素P-420或代谢物-中间体复合物。这些发现支持了这样一种假说,即8-MOP对细胞色素P-450的不可逆失活是由反应性代谢产物对脱辅基蛋白的修饰引起的。